RZLT (rezolutebio.com) Bozor qiymatining balans qiymatiga nisbati

Rezolute Inc (RZLT) kompaniyasining rasmiy ramzlari

Rezolute, Inc. (RZLT) o'z biznesini endokrin va kam uchraydigan metabolik buzilishlar uchun ilg'or terapiyalarni ishlab chiqishga asoslaydi va asosiy daromad oqimi glikemik nazorat dori vositalaridan kelishini kutmoqda. Tijoriy sotuvlar tartibga soluvchi qaror chiqquniga qadar mavjud emasligi sababli, joriy moliyaviy holat naqd pul zaxiralari bilan belgilanadi, 3.96 ko'rsatkichi esa tendentsiyani aks ettiradi. Ushbu narxlar grafigi yuqori marjali molekulalarga kelgusida monopoliya qilish orqali kengayish potentsialini namoyish etadi.

RZLT Rezolute Bio: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 28.10.2026 oraligʻida

Rezolute Inc (RZLT) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Rezolute, Inc.|RZLT - Tahlilchilarning prognoz narxlari
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Rezolute Corp|RZLT - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Rezolute|RZLT - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati rezolutebio.com|RZLT - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Rezolute, Inc.|RZLT - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Rezolute Corp|RZLT - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Rezolute Corp
Kompaniyaning dastlabki tahlili:Rezolute, Inc. - RZLT
Rezolute Corp original mahsuloti

Konservativ kapital yuqori texnologiyalar sektoriga investitsiya kiritishda xatarlarni minimallashtirish uchun aktivlar baholashida shaffoflikni talab qiladi. Ushbu ko'rsatkich biznesning bozor qiymatini uning sof aktivlari bilan solishtiradi va hyperinsulinizm uchun monopol dori vositasini yaratishda Rezolute, Inc. (RZLT) kompaniyasining kelajakdagi muvaffaqiyati uchun premiumni aks ettiradi, bu esa narxning buxgalteriya qiymatiga nisbati (price-to-book ratio) orqali yaqqol namoyon bo'ladi.

Asosiy raqobatchilar

ASND - Kapitallashuvning sof aktivlarga nisbati|MDGL (madrigalpharma.com) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor qiymatining balans qiymatiga nisbati Corcept Therapeutics Incorporated CORT|Sof aktivlarga nisbatan bozor kapitallashuvi Rhythm Pharma|Akero Therapeutics Inc (AKRO) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Metsera Therapeutics (MTSR)|Bozor kapitallashuvining balans qiymatiga nisbati MLTX (MoonLake Immunotherapeutics)|crinetics.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati NewAmsterdam Pharma Company N.V. (NAMS)|SLNO: Balans qiymatiga nisbatan bozor qiymati|FOLD (Amicus Pharma) - Bozor qiymatining balans qiymatiga nisbati|89bio Pharma (ETNB) - Kapitallashuvning sof aktivlarga nisbati|AGIO (Agios Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati structuretx.com (GPCR)|MiMedx (MDXG) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati LXRX (Lexicon Pharmaceuticals Inc)|MBX Bio - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Altimmune Pharma ALT|AARD (Aardvark Therapeutics Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|sagimet.com (SGMT) - Bozor qiymatining balans qiymatiga koeffitsiyenti|BIOA - Kapitallashuvning sof aktivlarga nisbati|Biomea Fusion Inc (BMEA) - Bozor kapitallashuvining balans qiymatiga multiplikatori|QNCX (Quince Therapeutics Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Fractyl Health, Inc|Bozor kapitallashuvining balans qiymatiga nisbati vTv Therapeutics Inc. (VTVT)|Bozor qiymatining balans qiymatiga nisbati ATPC (agapeatpgroup.com)|PLUR: Bozor qiymatining balans qiymatiga nisbati|Synlogic Inc. - Bozor qiymatining balans qiymatiga koeffitsiyenti|LPCN - Bozor qiymatining balans qiymatiga nisbati|MTNB - Bozor qiymatining balans qiymatiga nisbati|Spruce Biosciences - Bozor kapitallashuvining balans qiymatiga nisbati|GLTO (galecto.com) - Balans qiymatiga nisbatan bozor kapitallashuvi|CTCX: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi LUMO|Bozor qiymatining balans qiymatiga nisbati ONVO (Organovo Holdings Inc)|Kapitallashuvning sof aktivlarga nisbati RDUS (Radius Pharmaceuticals)